MartinSMaronMD

Adult Congenital Heart Disease

Assistant Professor of Medicine

Dr. Maron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
41 Mall Rd
Burlington, MA 01805
Phone+1 781-744-8000

Fax+1 617-636-6204

Martin Maron, MD, serves as the Director of the Hypertrophic Cardiomyopathy Center and the Co-Director of the Cardiac CT and MRI program at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imagining, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. He was the Hypertrophic Cardiomyopathy Association’s 2011 Clinician of the Year, and currently serves on the association’s Board of Directors. He is board certified in Cardiovascular Disease and Internal Medicine.

Tufts Medical CenterFellowship, Cardiovascular Disease, 2002 - 2005
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2001
Tulane University School of MedicineClass of 1999

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Fellow (FACC) American College of Cardiology

PubMed

Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
Usman A Tahir, Paul Kolm, Raymond Y Kwong, Milind Y Desai, Sarahfaye F Dolman
Circulation. Heart Failure. 2024-12-01
Diagnosis and management of hypertrophic cardiomyopathy: European vs. American guidelines.
Alberto Aimo, Giancarlo Todiere, Andrea Barison, Daniela Tomasoni, Giorgia Panichella
Heart Failure Reviews. 2024-11-09
1 citations
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa, Theodore P Abraham, Douglas Marshall Brinkley
European Heart Journal. 2024-11-08

Journal Articles

Mini-Focus Issue: Hypertrophic Cardiomyopathy State-of-the-Art Review Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy
Martin S Maron, Barry J Maron, James E Udelson, Ethan J Rowin, ScienceDirect

Lectures

HCM and its Many Variations: When to Suspect and How to Diagnose?
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Other

Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy
Maron MS, Elliott PM
http://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-evaluation-of-hypertrophic-ca
UpToDate, Wolters Kluwer Health - 2012-12-13
Overview of hypertrophic cardiomyopathy management including treatment of special problems
Maron MS
http://www.uptodate.com/contents/overview-of-hypertrophic-cardiomyopathy-management-including-treatm
UpToDate, Wolters Kluwer Health - 2012-12-06

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic CardiomyopathyOctober 28th, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCMOctober 28th, 2024
‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCMOctober 2nd, 2024
Join now to see all